Scilex Holding Company (SCLXW)
| Market Cap | 20.05M -24.9% |
| Revenue (ttm) | 31.61M -46.5% |
| Net Income | -448.35M |
| EPS | -51.60 |
| Shares Out | 7.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | 0.0425 - 0.3000 |
| Beta | 1.79 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About SCLXW
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of ... [Read more]
News
Scilex Holding Company Quarterly report: Q2 2026
Scilex Holding Company has published its Q2 2026 quarterly earnings report on August 14, 2026.
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the develo...
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and c...
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and c...
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026
PALO ALTO, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and c...
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
PALO ALTO, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and c...
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and c...
Scilex files to sell 2.08M shares of common stock
17:11 EDT Scilex (SCLX) files to sell 2.08M shares of common stock
Scilex files to sell 6.58M shares of common stock for holders
17:11 EDT Scilex (SCLX) files to sell 6.58M shares of common stock for holders
Scilex Holding Company Registration statement: Registration filing
Scilex Holding Company filed a registration statement on June 2, 2026, providing details about a securities offering with the SEC.
Scilex approves dividend of Semnur Pharmaceuticals shares
Scilex (SCLX) announced that its board of directors approved a dividend of Semnur Pharmaceuticals (SMNR) common stock held by the company to its stockholders and certain other eligible equityholders o...
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and co...
Scilex Holding Company Quarterly report: Q1 2026
Scilex Holding Company has published its Q1 2026 quarterly earnings report on May 20, 2026.
Scilex’s ACEA Thera, ACEA Pharma enter definitive agreement with Phoenix Asia
Scilex Holding Company (SCLX) announced that its indirect subsidiary, ACEA Therapeutics, ACEA Pharma, a wholly owned subsidiary of ACEA Thera, and Phoenix Asia Holdings (PHOE) entered into a stock acq...
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and co...
Scilex Holding Company Proxy statement: Proxy filing
Scilex Holding Company filed a proxy statement on May 5, 2026, providing details for shareholder voting and corporate governance matters.
Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026
PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and co...
Scilex Holding Company Proxy statement: Proxy filing
Scilex Holding Company filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Datavault to receive $120M cash contribution from Scilex
Datavault (DVLT) has executed a binding term sheet for a cash contribution and revenue participation agreement with Scilex (SCLX). The term sheet contemplates that Scilex will make an upfront cash…
Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform
Combined with the anticipated sale of the BTC and Receivable collections, Datavault AI projects $200M+ infusion of cash without equity dilution. Datavault AI has previously secured and in stock of Nvi...
Datavault executes term sheet for $120M cash contribution from Scilex
Datavault AI (DVLT) executed a binding term sheet for a cash contribution and revenue participation agreement with Scilex Holding Company (SCLX). The term sheet contemplates that Scilex will make an…
Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026
PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and ...
Scilex files $500M mixed securities shelf
17:12 EDT Scilex (SCLX) files $500M mixed securities shelf
Scilex Holding Company Registration statement: Registration filing
Scilex Holding Company filed a registration statement on April 16, 2026, providing details about a securities offering with the SEC.
Scilex Holding Co trading resumes
11:35 EDT Scilex (SCLX) Holding Co trading resumes